Precision medicine for advanced colorectal and gastroesophageal cancer

被引：0
|
作者：
Miguel Reyes, Jose [1 ]
机构：
[1] Clin Las Condes, Ctr Canc Maria Luisa Solari Falabella, Dept Oncol Med, Santiago, Chile
来源：
REVISTA MEDICA CLINICA LAS CONDES | 2022年 / 33卷 / 02期
关键词：
Esophageal Cancers; Gastric Cancer; Neoplasma; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; PHASE-III; FLUOROURACIL FAILURE; CONTINUOUS-INFUSION; 2ND-LINE TREATMENT; PLUS CHEMOTHERAPY; RANDOMIZED-TRIAL; GASTRIC-CANCER;
D O I：
10.1016/j.rmclc.2022.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Colorectal and gastroesophageal cancer have a global high incidence and a high mortality rate. Surgery persists as the only curative therapy for patients with early stages of both diseases. In those patients that are diagnosed with metastatic or unresectable cancer, or that become metastatic after locoregional treatment, chemotherapy has been the traditional therapy, with rather poor results in terms of survival or progression free survival. Precision medicine using molecular markers is changing this situation. Herein we review the most relevant aspects with regards to advances in the treatment of both diseases.
引用
收藏
页码：125 / 139
页数：15
相关论文
共 50 条
  • [1] Bringing Personalized Medicine to Precision Medicine in Gastroesophageal Cancer
    Chao, Joseph
    Mehta, Arnav
    Klempner, Samuel Jacob
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [2] Precision medicine in colorectal cancer
    Aziz, Mohammad Azhar
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (02): : 139 - 140
  • [3] Colorectal Cancer Precision Medicine
    Hendricks, William P. D.
    Edelstein, Daniel L.
    PRACTICAL GASTROENTEROLOGY, 2016, 40 (05) : 24 - 39
  • [4] Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
    Gambardella, Valentina
    Fleitas, Tania
    Tarazona, Noelia
    Papaccio, Federica
    Huerta, Marisol
    Rosello, Susana
    Gimeno-Valiente, Francisco
    Roda, Desamparados
    Cervantes, Andres
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 16
  • [5] Immunoscore for (colorectal) cancer precision medicine
    Ogino, Shuji
    Giannakis, Marios
    LANCET, 2018, 391 (10135): : 2084 - 2086
  • [6] Colorectal cancer in the era of precision medicine
    Borg, Christophe
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (09): : 1229 - 1233
  • [7] Precision medicine for advanced prostate cancer
    Mullane, Stephanie A.
    Van Allen, Eliezer M.
    CURRENT OPINION IN UROLOGY, 2016, 26 (03) : 231 - 239
  • [8] Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
    Cartry, Jerome
    Bedja, Sabrina
    Boileve, Alice
    Mathieu, Jacques R. R.
    Gontran, Emilie
    Annereau, Maxime
    Job, Bastien
    Mouawia, Ali
    Mathias, Pierre
    De Baere, Thierry
    Italiano, Antoine
    Besse, Benjamin
    Sourrouille, Isabelle
    Gelli, Maximiliano
    Bani, Mohamed-Amine
    Dartigues, Peggy
    Hollebecque, Antoine
    Smolenschi, Cristina
    Ducreux, Michel
    Malka, David
    Jaulin, Fanny
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [9] Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
    Jérôme Cartry
    Sabrina Bedja
    Alice Boilève
    Jacques R. R. Mathieu
    Emilie Gontran
    Maxime Annereau
    Bastien Job
    Ali Mouawia
    Pierre Mathias
    Thierry De Baère
    Antoine Italiano
    Benjamin Besse
    Isabelle Sourrouille
    Maximiliano Gelli
    Mohamed-Amine Bani
    Peggy Dartigues
    Antoine Hollebecque
    Cristina Smolenschi
    Michel Ducreux
    David Malka
    Fanny Jaulin
    Journal of Experimental & Clinical Cancer Research, 42
  • [10] Integrating precision medicine into the treatment of colorectal cancer
    Marshall, John L.
    ANNALS OF ONCOLOGY, 2019, 30
12345